Translating Translation to Mechanisms of Cardiac Hypertrophy

Michael J Zeitz1, James W Smyth1,2,3

  • 1Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA 24016, USA.

Insights

Pathological cardiac hypertrophy, a hallmark of heart disease, involves altered protein synthesis. Understanding these translational changes and targeting pathways like mTOR may reveal new treatments for heart failure.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Translational Medicine

Background:

  • Cardiac hypertrophy is a common response to chronic stress in heart disease.
  • This hypertrophy elevates risks for arrhythmias and heart failure.
  • Molecular mechanisms driving progression from hypertrophy to heart failure remain unclear.

Purpose of the Study:

  • To review the role of translational regulation in pathological cardiac hypertrophy.
  • To explore how altered protein synthesis contributes to disease progression.
  • To discuss therapeutic targets for controlling translational output.

Main Methods:

  • Review of recent studies on translational regulation in cardiac hypertrophy.
  • Analysis of how global and transcript-selective protein synthesis is modulated.
  • Examination of alternative translation modes in disease.

Main Results:

  • Translational machinery is modulated during pathological cardiac hypertrophy.
  • Enhanced global and transcript-selective protein synthesis occurs.
  • Alternative translation modes contribute to the disease state.

Conclusions:

  • Altered translational regulation is a key factor in pathological cardiac hypertrophy progression.
  • Targeting the mTOR pathway and other emerging targets shows therapeutic potential.
  • Further research into translational control mechanisms is crucial for developing heart failure treatments.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K